Colorectal cancer incidence, mortality, and stage distribution
in European countries in the colorectal cancer screening era:
an international population-based study

J 2021

Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study

CARDOSO, R.; F. GUO; T. HEISSER; M. HACKL; P. IHLE et al.

Základní údaje

Originální název

Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study

Autoři

Vydání

Lancet Oncology, New York, Elsevier Science INC, 2021, 1470-2045

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30204 Oncology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 54.433

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/21:00121970

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

colorectal cancer; incidence; mortality; stage distribution; Europe

Štítky

14119612, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 23. 7. 2021 13:32, Mgr. Tereza Miškechová

Anotace

V originále

Findings In countries with long-standing programmes of screening colonoscopy and faecal tests (ie, Austria, the Czech Republic, and Germany), colorectal cancer incidence decreased substantially over time, with AAPCs ranging from -2 center dot 5% (95% CI -2 center dot 8 to -2 center dot 2) to -1 center dot 6% (-2 center dot 0 to -1 center dot 2) in men and from -2 center dot 4% (-2 center dot 7 to -2 center dot 1) to -1 center dot 3% (-1 center dot 7 to -0 center dot 9) in women. In countries where screening programmes were implemented during the study period, age-standardised colorectal cancer incidence either remained stable or increased up to the year screening was implemented. AAPCs for these countries ranged from -0 center dot 2% (95% CI -1 center dot 4 to 1 center dot 0) to 1 center dot 5% (1 center dot 1 to 1 center dot 8) in men and from -0 center dot 5% (-1 center dot 7 to 0 center dot 6) to 1 center dot 2% (0 center dot 8 to 1 center dot 5) in women. Where high screening coverage and uptake were rapidly achieved (ie, Denmark, the Netherlands, and Slovenia), age-standardised incidence rates initially increased but then subsequently decreased. Conversely, colorectal cancer incidence increased in most countries where no large-scale screening programmes were available (eg, Bulgaria, Estonia, Norway, and Ukraine), with AAPCs ranging from 0 center dot 3% (95% CI 0 center dot 1 to 0 center dot 5) to 1 center dot 9% (1 center dot 2 to 2 center dot 6) in men and from 0 center dot 6% (0 center dot 4 to 0 center dot 8) to 1 center dot 1% (0 center dot 8 to 1 center dot 4) in women. The largest decreases in colorectal cancer mortality were seen in countries with long-standing screening programmes.

Citovat

CARDOSO, R.; F. GUO; T. HEISSER; M. HACKL; P. IHLE; H. DE SCHUTTER; N. VAN DAMME; Z. VALERIANOVA; T. ATANASOV; Ondřej MÁJEK; Jan MUŽÍK; M. C. NILBERT; A. J. TYBJERG; K. INNOS; M. MAGI; N. MALILA; A. M. BOUVIER; V. BOUVIER; G. LAUNOY; A. S. WORONOFF; M. CARIOU; M. ROBASZKIEWICZ; P. DELAFOSSE; F. PONCET; A. KATALINIC; P. M. WALSH; C. SENORE; S. ROSSO; I. VINCERZEVSKIENE; V. E. P. P. LEMMENS; M. A. G. ELFERINK; T. B. JOHANNESEN; H. KORNER; F. PFEFFER; M. J. BENTO; J. RODRIGUES; F. A. DA COSTA; A. MIRANDA; V. ZADNIK; T. ZAGAR; A. L. D. MARQUES; R. MARCOS-GRAGERA; M. PUIGDEMONT; J. GALCERAN; M. CARULLA; M. D. CHIRLAQUE; M. BALLESTA; K. SUNDQUIST; J. SUNDQUIST; M. WEBER; A. JORDAN; C. HERRMANN; M. MOUSAVI; A. RYZHOV; M. HOFFMEISTER a H. BRENNER. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncology. New York: Elsevier Science INC, 2021, roč. 22, č. 7, s. 1002-1013. ISSN 1470-2045. Dostupné z: https://doi.org/10.1016/S1470-2045(21)00199-6.

@article{1783532,
   author = {Cardoso, R. and Guo, F. and Heisser, T. and Hackl, M. and Ihle, P. and De Schutter, H. and Van Damme, N. and Valerianova, Z. and Atanasov, T. and Májek, Ondřej and Mužík, Jan and Nilbert, M. C. and Tybjerg, A. J. and Innos, K. and Magi, M. and Malila, N. and Bouvier, A. M. and Bouvier, V. and Launoy, G. and Woronoff, A. S. and Cariou, M. and Robaszkiewicz, M. and Delafosse, P. and Poncet, F. and Katalinic, A. and Walsh, P. M. and Senore, C. and Rosso, S. and Vincerzevskiene, I. and Lemmens, V. E. P. P. and Elferink, M. A. G. and Johannesen, T. B. and Korner, H. and Pfeffer, F. and Bento, M. J. and Rodrigues, J. and da Costa, F. A. and Miranda, A. and Zadnik, V. and Zagar, T. and Marques, A. L. D. and MarcosandGragera, R. and Puigdemont, M. and Galceran, J. and Carulla, M. and Chirlaque, M. D. and Ballesta, M. and Sundquist, K. and Sundquist, J. and Weber, M. and Jordan, A. and Herrmann, C. and Mousavi, M. and Ryzhov, A. and Hoffmeister, M. and Brenner, H.},
   article_location = {New York},
   article_number = {7},
   doi = {https://doi.org/10.1016/S1470-2045(21)00199-6},
   keywords = {colorectal cancer; incidence; mortality; stage distribution; Europe},
   language = {eng},
   issn = {1470-2045},
   journal = {Lancet Oncology},
   title = {Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study},
   url = {https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00199-6/fulltext},
   volume = {22},
   year = {2021}
}

TY  - JOUR
ID  - 1783532
AU  - Cardoso, R. - Guo, F. - Heisser, T. - Hackl, M. - Ihle, P. - De Schutter, H. - Van Damme, N. - Valerianova, Z. - Atanasov, T. - Májek, Ondřej - Mužík, Jan - Nilbert, M. C. - Tybjerg, A. J. - Innos, K. - Magi, M. - Malila, N. - Bouvier, A. M. - Bouvier, V. - Launoy, G. - Woronoff, A. S. - Cariou, M. - Robaszkiewicz, M. - Delafosse, P. - Poncet, F. - Katalinic, A. - Walsh, P. M. - Senore, C. - Rosso, S. - Vincerzevskiene, I. - Lemmens, V. E. P. P. - Elferink, M. A. G. - Johannesen, T. B. - Korner, H. - Pfeffer, F. - Bento, M. J. - Rodrigues, J. - da Costa, F. A. - Miranda, A. - Zadnik, V. - Zagar, T. - Marques, A. L. D. - Marcos-Gragera, R. - Puigdemont, M. - Galceran, J. - Carulla, M. - Chirlaque, M. D. - Ballesta, M. - Sundquist, K. - Sundquist, J. - Weber, M. - Jordan, A. - Herrmann, C. - Mousavi, M. - Ryzhov, A. - Hoffmeister, M. - Brenner, H.
PY  - 2021
TI  - Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study
JF  - Lancet Oncology
VL  - 22
IS  - 7
SP  - 1002-1013
EP  - 1002-1013
PB  - Elsevier Science INC
SN  - 14702045
KW  - colorectal cancer
KW  - incidence
KW  - mortality
KW  - stage distribution
KW  - Europe
UR  - https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00199-6/fulltext
N2  - Findings In countries with long-standing programmes of screening colonoscopy and faecal tests (ie, Austria, the Czech Republic, and Germany), colorectal cancer incidence decreased substantially over time, with AAPCs ranging from -2 center dot 5% (95% CI -2 center dot 8 to -2 center dot 2) to -1 center dot 6% (-2 center dot 0 to -1 center dot 2) in men and from -2 center dot 4% (-2 center dot 7 to -2 center dot 1) to -1 center dot 3% (-1 center dot 7 to -0 center dot 9) in women. In countries where screening programmes were implemented during the study period, age-standardised colorectal cancer incidence either remained stable or increased up to the year screening was implemented. AAPCs for these countries ranged from -0 center dot 2% (95% CI -1 center dot 4 to 1 center dot 0) to 1 center dot 5% (1 center dot 1 to 1 center dot 8) in men and from -0 center dot 5% (-1 center dot 7 to 0 center dot 6) to 1 center dot 2% (0 center dot 8 to 1 center dot 5) in women. Where high screening coverage and uptake were rapidly achieved (ie, Denmark, the Netherlands, and Slovenia), age-standardised incidence rates initially increased but then subsequently decreased. Conversely, colorectal cancer incidence increased in most countries where no large-scale screening programmes were available (eg, Bulgaria, Estonia, Norway, and Ukraine), with AAPCs ranging from 0 center dot 3% (95% CI 0 center dot 1 to 0 center dot 5) to 1 center dot 9% (1 center dot 2 to 2 center dot 6) in men and from 0 center dot 6% (0 center dot 4 to 0 center dot 8) to 1 center dot 1% (0 center dot 8 to 1 center dot 4) in women. The largest decreases in colorectal cancer mortality were seen in countries with long-standing screening programmes.
ER  -

CARDOSO, R.; F. GUO; T. HEISSER; M. HACKL; P. IHLE; H. DE SCHUTTER; N. VAN DAMME; Z. VALERIANOVA; T. ATANASOV; Ondřej MÁJEK; Jan MUŽÍK; M. C. NILBERT; A. J. TYBJERG; K. INNOS; M. MAGI; N. MALILA; A. M. BOUVIER; V. BOUVIER; G. LAUNOY; A. S. WORONOFF; M. CARIOU; M. ROBASZKIEWICZ; P. DELAFOSSE; F. PONCET; A. KATALINIC; P. M. WALSH; C. SENORE; S. ROSSO; I. VINCERZEVSKIENE; V. E. P. P. LEMMENS; M. A. G. ELFERINK; T. B. JOHANNESEN; H. KORNER; F. PFEFFER; M. J. BENTO; J. RODRIGUES; F. A. DA COSTA; A. MIRANDA; V. ZADNIK; T. ZAGAR; A. L. D. MARQUES; R. MARCOS-GRAGERA; M. PUIGDEMONT; J. GALCERAN; M. CARULLA; M. D. CHIRLAQUE; M. BALLESTA; K. SUNDQUIST; J. SUNDQUIST; M. WEBER; A. JORDAN; C. HERRMANN; M. MOUSAVI; A. RYZHOV; M. HOFFMEISTER a H. BRENNER. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. \textit{Lancet Oncology}. New York: Elsevier Science INC, 2021, roč.~22, č.~7, s.~1002-1013. ISSN~1470-2045. Dostupné z: https://doi.org/10.1016/S1470-2045(21)00199-6.

Přehled o publikaci